Madrigal Pharmaceuticals, Inc

(NASDAQ:MDGL)

Latest On Madrigal Pharmaceuticals, Inc (MDGL):

Date/Time Type Description Signal Details
2023-05-30 02:23 ESTNewsDrug pricing watchdog raises alarm over upcoming liver disease medsN/A
2023-05-30 02:23 ESTNewsMadrigal: Setting The Pace In The NASH Market (Rating Upgrade)N/A
2023-04-18 12:35 ESTNewsMadrigal rises on FDA breakthrough therapy tag for liver disease drug resmetiromN/A
2023-03-31 07:29 ESTNewsMadrigal Pharmaceuticals: Odds Shortening On NASH Drug ApprovalN/A
2023-02-23 17:08 ESTNewsMadrigal Pharmaceuticals GAAP EPS of -$4.98 misses by $0.48N/A
2023-01-17 22:03 ESTNewsMadrigal: Fairly Valued At These LevelsN/A
2023-01-06 14:12 ESTNewsMadrigal Pharmaceuticals releases additional late-stage data on resmetirom for NASHN/A
2022-12-26 18:09 ESTNewsMadrigal Pharmaceuticals Setting The StandardN/A
2022-12-23 10:45 ESTNewsMadrigal Pharmaceuticals: Upcoming Windfall ProfitsN/A
2022-12-22 00:50 ESTNewsMadrigal Pharmaceuticals Is Still Undervalued After Resmetirom's Phase 3 SuccessN/A
2022-12-22 00:50 ESTNewsMadrigal: Next Steps After 'Wow' Data In NASHN/A
2022-12-19 21:29 ESTNewsMadrigal closes up 268% on positive late-stage results for NASH candidate resmetiromN/A
2022-12-14 02:23 ESTNewsMadrigal Pharmaceuticals: The Wait For Pivotal NASH Data Must End SoonN/A
2022-12-13 08:52 ESTNewsMadrigal: Binary Catalyst UnlockingN/A
2022-11-03 12:10 ESTNewsMadrigal Pharmaceuticals GAAP EPS of -$4.75 misses by $0.61N/A
2022-10-29 22:36 ESTNewsMadrigal Pharmaceuticals Forecast: Not So ClearN/A
2022-10-25 13:49 ESTNewsMadrigal: End Of 2022 NASH Data For Multi-Billion Dollar MarketN/A
2022-08-04 13:47 ESTNewsMadrigal Pharmaceuticals GAAP EPS of -$4.14 misses by $0.46N/A
2022-08-04 13:47 ESTNewsMadrigal: Buy And Hoard Before Q4 Data ReadoutN/A
2022-07-08 22:48 ESTNewsMadrigal cut to Neutral at B. Riley on concerns over upcoming NASH readoutN/A
2022-06-19 03:29 ESTNewsMadrigal Pharmaceuticals (MDGL) Investor Presentation - SlideshowN/A
2022-05-09 13:14 ESTNewsMadrigal Pharmaceuticals GAAP EPS of -$3.36 beats by $0.20N/A
2022-05-09 13:14 ESTNewsMadrigal Pharmaceuticals, Inc. (MDGL) CEO Paul Friedman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-22 14:34 ESTNewsMadrigal: Clear Path AheadN/A
2022-04-20 01:06 ESTNewsMadrigal: NASH Data In Q4 Is The KeyN/A
2022-02-24 15:25 ESTNewsMadrigal Pharmaceuticals Q4 net loss widens Y/YN/A
2022-02-02 05:21 ESTNewsMadrigal NASH Data Is Promising, Next Study Is Key For SuccessN/A
2022-01-31 19:50 ESTNewsMadrigal says liver disease candidate improved key patient outcomes in late-stage studyN/A
2022-01-31 19:50 ESTNewsMadrigal: Delayed NASH Data Is Positive But Real Tests Are Still To ComeN/A
2022-01-09 11:19 ESTNewsMadrigal: Powerful Catalyst ApproachingN/A
2021-12-30 15:18 ESTNewsMadrigal expects delay in results from phase 3 trial of liver drug resmetiromN/A
2021-12-30 15:17 ESTNewsMadrigal rises as H. C. Wainwright defends after delay in liver disease trialN/A
2021-11-19 15:55 ESTNewsMadrigal Pharmaceuticals (MDGL) Presents At The Virtual Lever Meeting 2021 - SlideshowN/A
2021-11-15 08:36 ESTNewsMadrigal: Major Catalyst Coming UpN/A
2021-11-13 00:34 ESTNewsMadrigal shares data from open-label study for its liver disease therapy resmetiromN/A
2021-11-04 12:38 ESTNewsMadrigal Pharmaceuticals EPS beats by $0.09N/A
2021-10-10 00:01 ESTNewsA look at the biopharmas developing new treatments for liver diseasesN/A
2021-10-06 12:51 ESTNewsMDGL is at high risk of performing badlyN/A
2021-09-27 21:39 ESTNewsWarning: MDGL has been downgraded to Very BearishN/A
2021-09-24 09:04 ESTNewsWarning: MDGL has been downgraded to Very Bearish.N/A
2021-08-05 08:25 ESTNewsMadrigal Pharmaceuticals EPS misses by $0.14N/A
2021-07-21 15:40 ESTNewsNGM Biopharma price target cut by more than half at Raymond James after NASH setbackN/A
2021-07-21 15:26 ESTNewsMadrigal Pharma announces “positive” data from NASH trialN/A
2021-07-21 15:24 ESTNewsMadrigal Pharma completes enrollment of liver biopsy patients in late-stage MAESTRO-NASH studyN/A
2021-07-21 15:14 ESTNewsDosing underway in Madrigal Pharma's extension study of Phase 3 MAESTRO-NAFLD-1 trialN/A
2021-05-06 15:29 ESTNewsMadrigal Pharmaceuticals EPS beats by $0.44N/A
2021-05-05 19:31 ESTNewsMadrigal Pharmaceuticals: Leading The NASH InnovationN/A
2021-03-16 21:22 ESTAnalyst RatingThe Analyst Target Price has increased from $170.07 to $170.36.Buy
2021-03-03 00:27 ESTAnalyst RatingThe Analyst Target Price has increased from $169.93 to $170.07.Buy
2021-03-02 00:14 ESTAnalyst RatingThe Analyst Target Price has decreased from $170.57 to $169.93.Neutral

About Madrigal Pharmaceuticals, Inc (MDGL):

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

MDGL Quotes by TradingView

See Advanced Chart

General

  • Name Madrigal Pharmaceuticals, Inc
  • Symbol MDGL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 42
  • Last Split Factor1:35
  • Last Split Date2016-07-25
  • Fiscal Year EndDecember
  • IPO Date2007-02-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.madrigalpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 7.87
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$16.21
  • Next Year EPS Estimate -$14.67
  • Next Quarter EPS Estimate -$3.80
  • Return on Assets -35%
  • Return on Equity -62%
  • Earnings Per Share -$3.57
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.89 billion
  • EBITDA -66505000
  • Analyst Target Price $170.36
  • Book Value Per Share $15.47
View More

Share Statistics

  • Shares Outstanding 15.47 million
  • Shares Float 7.18 million
  • % Held by Insiders 1947%
  • % Held by Institutions 93.86%
  • Shares Short 2.66 million
  • Shares Short Prior Month 2.77 million
  • Short Ratio 10.52
  • Short % of Float 31%
  • Short % of Shares Outstanding 17%
View More

Technicals

  • Beta 1.12
  • 52 Week High $136.81
  • 52 Week Low $56.82
  • 50 Day Moving Average 118.41
  • 200 Day Moving Average 118.57
View More

Dividends

  • Dividend Date 2016-07-25
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Madrigal Pharmaceuticals, Inc (MDGL) Dividend Calendar:

MDGL's last dividend payment was made to shareholders on July 25, 2016.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Madrigal Pharmaceuticals, Inc (MDGL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$3.82-$3.902.08%
2020-09-302020-11-05$N/A-$3.75-$3.30-13.64%
2020-06-302020-08-06$N/A-$3.18-$2.43-30.64%
2020-03-312020-05-07$N/A-$2.34-$1.95-20.3%
2019-12-312020-02-26$N/A-$1.80-$1.67-7.71%
2019-09-302019-11-06$N/A-$1.39-$1.422.11%
2019-06-302019-08-07$N/A-$1.28-$1.22-4.75%
2019-03-312019-05-08$N/A-$0.98-$0.97-1.39%
2018-12-312019-02-27$N/A-$0.76-$0.74-2.11%
2018-09-302018-11-06$N/A-$0.56-$0.53-6.18%
2018-06-302018-08-07$200000-$0.45-$0.6227.8%
2018-03-312018-05-08$N/A-$0.45-$0.7741.45%
2017-12-312018-03-13$250000-$0.67-$0.704.01%
2017-09-302017-11-09$100000-$0.68-$0.7913.56%
2017-06-302017-08-10$N/A-$0.69-$0.60-15%
2017-03-312017-05-11$N/A-$0.50-$0.8742.53%
2016-12-312017-03-31$N/A-$2.83-$1.39-103.6%
2016-09-302016-11-14$N/A-$1.59-$0.35-354.29%
2016-06-302016-07-20$N/A-$0.70-$0.700%
2016-03-312016-05-10$N/A-$1.75-$1.05-66.67%
2015-12-312016-03-15$N/A-$2.80-$5.6050%
2015-09-302015-11-05$N/A-$4.55-$5.6018.75%
2015-06-302015-08-06$N/A-$5.25-$6.3617.45%
2015-03-312015-05-07$N/A-$6.65-$6.873.2%
2014-12-312015-03-12$N/A-$6.65-$7.288.65%
2014-09-302014-11-06$N/A-$6.65-$8.4621.39%
2014-06-302014-08-06$N/A-$8.40-$9.339.97%
2014-03-312014-05-08$N/A-$9.80-$10.032.29%
2013-12-312014-03-11$N/A-$10.85-$10.50-3.33%
2013-09-302013-11-04$N/A-$11.55-$10.72-7.74%
2013-06-302013-08-01$N/A-$11.55-$10.32-11.92%
2013-03-312013-04-30$N/A-$10.50-$9.36-12.18%
2012-12-312013-03-14$N/A-$10.15-$9.15-10.93%
2012-09-302012-11-06$N/A-$8.75-$8.28-5.68%
2012-06-302012-08-02$N/A-$8.75-$9.305.91%
2012-03-312012-05-03$147000-$9.45-$8.63-9.5%
2011-12-312012-02-22-$7.70-$9.3517.65%
2011-09-302011-11-03$1.66 million-$10.50-$9.97-5.32%
2011-06-302011-08-04$1.35 million-$10.50-$6.79-54.64%
2011-03-312011-05-05-$9.45-$9.742.98%
2010-12-312011-03-11-$7.48
2010-09-302010-11-04-$8.75-$7.70-13.64%
2010-06-302010-08-09-$7.70-$8.054.35%
2010-03-312010-05-04-$8.40-$7.35-14.29%
2009-12-312010-03-11-$7.35-$8.6114.63%
2009-09-302009-11-04$121.80$61.2598.86%
2009-06-302009-08-04-$8.75-$11.7225.34%
2009-03-312009-05-07-$24.15-$18.78-28.59%
2008-12-312009-03-26-$26.95-$30.7312.3%
2008-09-302008-11-13-$27.30-$23.05-18.44%
2008-06-302008-08-07-$23.45-$20.25-15.8%
2008-03-312008-05-14-$18.20-$18.11-0.5%
2007-12-312008-03-20-$16.10-$17.648.73%
2007-09-302007-11-13-$15.75-$20.0721.52%
2007-06-302007-08-06-$17.50-$18.435.05%
2007-03-312007-05-07-$19.95-$17.03-17.15%
2006-12-312007-03-29-$20.90

Madrigal Pharmaceuticals, Inc (MDGL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Madrigal Pharmaceuticals, Inc (MDGL) Chart:

MDGL chart by TradingView

Madrigal Pharmaceuticals, Inc (MDGL) News:

Below you will find a list of latest news for Madrigal Pharmaceuticals, Inc (MDGL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Madrigal Pharmaceuticals, Inc (MDGL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-1765144.57CALL0 25492.32TRUE00
2025-01-1770212.66CALL0 091.22TRUE00
2025-01-17750CALL0 0101.94TRUE00
2025-01-17800CALL0 086.75TRUE00
2025-01-17850CALL0 085.3TRUE00
2025-01-1790147.8CALL0 383.32TRUE00
2025-01-1795125.8CALL0 281TRUE00
2025-01-17100117CALL0 4783.43TRUE00
2025-01-17105171.5CALL0 377.15TRUE00
2025-01-17110125.55CALL0 676.51TRUE00
2025-01-171150CALL0 074.35TRUE00
2025-01-17120136.9CALL0 1074.5TRUE00
2025-01-17125168.12CALL0 074.97TRUE00
2025-01-17130106.5CALL0 573.48TRUE00
2025-01-17135147CALL0 172.8TRUE00
2025-01-17140123.1CALL0 569.96TRUE00
2025-01-17145128.9CALL0 369.81TRUE00
2025-01-1715075.45CALL0 1568.55TRUE00
2025-01-1715560CALL0 1568.31TRUE00
2025-01-1716093.8CALL0 90567.99TRUE00
2025-01-17165100CALL0 1366.3TRUE00
2025-01-1717095.2CALL0 665.6TRUE00
2025-01-17175130.6CALL0 362.84TRUE00
2025-01-1718069.91CALL0 763.23TRUE00
2025-01-17185119.8CALL0 10264.87TRUE00
2025-01-1719053.44CALL0 5462.53TRUE00
2025-01-1719539.45CALL0 2765.28TRUE00
2025-01-1720036.5CALL0 4360.88TRUE00
2025-01-1721029.38CALL3 63162.84FALSE-1.89-0.06
2025-01-1722054.53CALL0 1961.38FALSE00
2025-01-1723046CALL0 2762.19FALSE00
2025-01-1724023.49CALL0 7861.18FALSE00
2025-01-1725014CALL10 11658.76FALSE-2.41-0.15
2025-01-1726013.2CALL0 6061.66FALSE00
2025-01-1727011.67CALL0 27158.96FALSE00
2025-01-1728010.18CALL0 7358.8FALSE00
2025-01-172907.57CALL0 3859.19FALSE00
2025-01-173006.76CALL0 44560.41FALSE00
2025-01-1731014.25CALL0 2557.58FALSE00
2025-01-173207.2CALL0 4857.36FALSE00
2025-01-173303.4CALL0 2062.53FALSE00
2025-01-173407.4CALL0 1761.93FALSE00
2025-01-173502.5CALL1 6860.75FALSE2.50
2025-01-1736010.2CALL0 120FALSE00
2025-01-173701.9CALL6 1061.91FALSE1.90
2025-01-173802.5CALL0 1810FALSE00
2025-01-173909.2CALL0 1172.18FALSE00
2025-01-174002.85CALL0 8275.7FALSE00
2025-01-1741011.35CALL0 975.26FALSE00
2025-01-1742012.8CALL0 130FALSE00
2025-01-1743011CALL0 11670FALSE00
2025-01-1744010.35CALL0 18820FALSE00
2025-01-174504CALL0 8210FALSE00
2025-01-174600.2CALL0 211382.87FALSE00
2025-01-17650.3PUT0 1530FALSE00
2025-01-17700.35PUT0 1190FALSE00
2025-01-17750.8PUT0 430FALSE00
2025-01-17800.95PUT0 3598.27FALSE00
2025-01-17851.2PUT0 280FALSE00
2025-01-17900.8PUT0 380FALSE00
2025-01-17951.7PUT0 1296.87FALSE00
2025-01-171000.55PUT0 8886.19FALSE00
2025-01-171051.45PUT0 100FALSE00
2025-01-171101.46PUT0 290FALSE00
2025-01-171152.05PUT0 474.12FALSE00
2025-01-171202.3PUT0 60FALSE00
2025-01-171251.45PUT0 230FALSE00
2025-01-1713034.1PUT0 270.81FALSE00
2025-01-171357.35PUT0 669.38FALSE00
2025-01-171405.2PUT0 10768.57FALSE00
2025-01-1714510PUT0 12665FALSE00
2025-01-171503.52PUT0 86066.05FALSE00
2025-01-171557PUT1 1467.04FALSE70
2025-01-171605.7PUT0 65164.04FALSE00
2025-01-171659PUT0 3462.14FALSE00
2025-01-171706.5PUT0 20565.25FALSE00
2025-01-171757.5PUT0 6663.25FALSE00
2025-01-1718012.5PUT0 9064.44FALSE00
2025-01-1718510.52PUT0 11361.76FALSE00
2025-01-1719011.34PUT0 7361.53FALSE00
2025-01-1719511.3PUT0 16360.47FALSE00
2025-01-1720014.8PUT0 46062.95FALSE00
2025-01-1721026.4PUT1 4360.58TRUE-0.2-0.01
2025-01-1722029.22PUT0 5658.93TRUE00
2025-01-1723028PUT0 18461.96TRUE00
2025-01-1724040.38PUT0 20158.53TRUE00
2025-01-1725053.56PUT1 54062.8TRUE53.560
2025-01-1726040.73PUT0 9758.48TRUE00
2025-01-1727044.3PUT0 9959.76TRUE00
2025-01-1728054.1PUT0 457.93TRUE00
2025-01-1729049.1PUT0 8257.9TRUE00
2025-01-1730077.25PUT0 657.34TRUE00
2025-01-1731082PUT0 158.11TRUE00
2025-01-17320129.5PUT0 4355.5TRUE00
2025-01-17330134.3PUT0 057.1TRUE00
2025-01-17340147.3PUT0 060.37TRUE00
2025-01-1735080PUT0 161.49TRUE00
2025-01-17360125PUT0 162.23TRUE00
2025-01-173700PUT0 087.46TRUE00
2025-01-173800PUT0 064.97TRUE00
2025-01-173900PUT0 068.12TRUE00
2025-01-17400164PUT0 070.4TRUE00
2025-01-174100PUT0 070.81TRUE00
2025-01-17420186.17PUT0 073.92TRUE00
2025-01-17430188.4PUT0 076.87TRUE00
2025-01-17440188.4PUT0 078.92TRUE00
2025-01-17450233.5PUT0 080.92TRUE00
2025-01-17460222.1PUT0 082.87TRUE00
2025-04-171100CALL0 067.59TRUE00
2025-04-171150CALL0 066.38TRUE00
2025-04-171200CALL0 066.34TRUE00
2025-04-171250CALL0 064.22TRUE00
2025-04-171300CALL0 064.35TRUE00
2025-04-171350CALL0 063.56TRUE00
2025-04-171400CALL0 062.84TRUE00
2025-04-171450CALL0 062.04TRUE00
2025-04-171500CALL0 062.39TRUE00
2025-04-171550CALL0 061.24TRUE00
2025-04-171600CALL0 062.78TRUE00
2025-04-171650CALL0 062.1TRUE00
2025-04-171700CALL0 061.86TRUE00
2025-04-171750CALL0 061.08TRUE00
2025-04-171800CALL0 060.63TRUE00
2025-04-171850CALL0 060.26TRUE00
2025-04-171900CALL0 060.35TRUE00
2025-04-171950CALL0 060.13TRUE00
2025-04-172000CALL0 059.38TRUE00
2025-04-1721036.75CALL2 257.25FALSE36.750
2025-04-1722034.38CALL0 258.38FALSE00
2025-04-1723037.8CALL0 257.45FALSE00
2025-04-1724042.2CALL0 257.15FALSE00
2025-04-1725022CALL1 055.78FALSE220
2025-04-172600CALL0 054.74FALSE00
2025-04-1727018.17CALL0 655.06FALSE00
2025-04-1728019.68CALL0 355.19FALSE00
2025-04-1729014.8CALL0 553.84FALSE00
2025-04-1730015.6CALL0 1855.11FALSE00
2025-04-173100CALL0 054.35FALSE00
2025-04-1732012.45CALL0 353.67FALSE00
2025-04-173300CALL0 053.5FALSE00
2025-04-173400CALL0 054.14FALSE00
2025-04-173500CALL0 051.25FALSE00
2025-04-1736010.9CALL0 153.22FALSE00
2025-04-173700CALL0 052.25FALSE00
2025-04-173800CALL0 054.37FALSE00
2025-04-171100PUT0 066.97FALSE00
2025-04-171150PUT0 068.39FALSE00
2025-04-171200PUT0 067.61FALSE00
2025-04-171257.15PUT0 165.86FALSE00
2025-04-171300PUT0 064.92FALSE00
2025-04-171355.1PUT0 264.61FALSE00
2025-04-171405.8PUT0 261.95FALSE00
2025-04-171456.7PUT0 261.23FALSE00
2025-04-171500PUT0 059.18FALSE00
2025-04-171550PUT0 060.16FALSE00
2025-04-171600PUT0 062.47FALSE00
2025-04-171650PUT0 062.01FALSE00
2025-04-171700PUT0 060.91FALSE00
2025-04-171750PUT0 060.68FALSE00
2025-04-171800PUT0 060.31FALSE00
2025-04-171850PUT0 059.75FALSE00
2025-04-1719021PUT0 258.99FALSE00
2025-04-171950PUT0 058.15FALSE00
2025-04-172000PUT0 058.36FALSE00
2025-04-1721032.53PUT1 056.48TRUE32.530
2025-04-1722039.2PUT1 357.87TRUE39.20
2025-04-1723030.25PUT0 156.07TRUE00
2025-04-1724038.44PUT0 1056.15TRUE00
2025-04-1725042.1PUT0 5256.13TRUE00
2025-04-1726049.06PUT0 4055.09TRUE00
2025-04-1727055.63PUT0 4554.67TRUE00
2025-04-172800PUT0 054.62TRUE00
2025-04-172900PUT0 054.3TRUE00
2025-04-173000PUT0 054.34TRUE00
2025-04-173100PUT0 053.98TRUE00
2025-04-173200PUT0 053.4TRUE00
2025-04-173300PUT0 053.04TRUE00
2025-04-173400PUT0 053.28TRUE00
2025-04-173500PUT0 050.78TRUE00
2025-04-173600PUT0 054.68TRUE00
2025-04-173700PUT0 052.59TRUE00
2025-04-173800PUT0 054.55TRUE00
2025-12-191100CALL0 059.79TRUE00
2025-12-191150CALL0 058.99TRUE00
2025-12-191200CALL0 057.59TRUE00
2025-12-191250CALL0 058.39TRUE00
2025-12-191300CALL0 057.01TRUE00
2025-12-191350CALL0 057.35TRUE00
2025-12-191400CALL0 056TRUE00
2025-12-191450CALL0 056.19TRUE00
2025-12-191500CALL0 056.19TRUE00
2025-12-191550CALL0 056.2TRUE00
2025-12-191600CALL0 056.3TRUE00
2025-12-191650CALL0 056.17TRUE00
2025-12-191700CALL0 055.29TRUE00
2025-12-191750CALL0 055.7TRUE00
2025-12-191800CALL0 055.32TRUE00
2025-12-191850CALL0 055.16TRUE00
2025-12-191900CALL0 054.28TRUE00
2025-12-191950CALL0 053.64TRUE00
2025-12-192000CALL0 053.9TRUE00
2025-12-192100CALL0 052.65FALSE00
2025-12-192200CALL0 052.44FALSE00
2025-12-192300CALL0 052.42FALSE00
2025-12-192400CALL0 051.28FALSE00
2025-12-192500CALL0 151.57FALSE00
2025-12-192600CALL0 050.58FALSE00
2025-12-192700CALL0 050.7FALSE00
2025-12-192800CALL0 050.49FALSE00
2025-12-192900CALL0 049.85FALSE00
2025-12-193000CALL0 049.44FALSE00
2025-12-193100CALL0 049.11FALSE00
2025-12-1932022.76CALL0 148.7FALSE00
2025-12-193300CALL0 048.85FALSE00
2025-12-193400CALL0 047.82FALSE00
2025-12-193500CALL0 047.69FALSE00
2025-12-191100PUT0 058.84FALSE00
2025-12-191150PUT0 059.68FALSE00
2025-12-191200PUT0 060.38FALSE00
2025-12-191250PUT0 059.46FALSE00
2025-12-191300PUT0 058.45FALSE00
2025-12-191350PUT0 059.75FALSE00
2025-12-191400PUT0 058.83FALSE00
2025-12-191450PUT0 058.17FALSE00
2025-12-191500PUT0 056.76FALSE00
2025-12-191550PUT0 056.25FALSE00
2025-12-191600PUT0 055.79FALSE00
2025-12-191650PUT0 055.87FALSE00
2025-12-191700PUT0 056.65FALSE00
2025-12-191750PUT0 055.51FALSE00
2025-12-191800PUT0 054.17FALSE00
2025-12-191850PUT0 054.26FALSE00
2025-12-191900PUT0 053.86FALSE00
2025-12-191950PUT0 053.31FALSE00
2025-12-192000PUT0 054.05FALSE00
2025-12-192100PUT0 052.91TRUE00
2025-12-192200PUT0 052.09TRUE00
2025-12-192300PUT0 051.57TRUE00
2025-12-192400PUT0 050.63TRUE00
2025-12-192500PUT0 050.86TRUE00
2025-12-192600PUT0 049.87TRUE00
2025-12-192700PUT0 050.05TRUE00
2025-12-192800PUT0 048.95TRUE00
2025-12-192900PUT0 048.92TRUE00
2025-12-193000PUT0 048.72TRUE00
2025-12-193100PUT0 049.08TRUE00
2025-12-193200PUT0 048.55TRUE00
2025-12-193300PUT0 048.42TRUE00
2025-12-193400PUT0 048.73TRUE00
2025-12-193500PUT0 048.22TRUE00
2026-01-16105159.59CALL0 157.91TRUE00
2026-01-16110149.35CALL0 1358.56TRUE00
2026-01-161150CALL0 058.6TRUE00
2026-01-161200CALL0 057.25TRUE00
2026-01-161250CALL0 057.17TRUE00
2026-01-16130101.42CALL0 156.99TRUE00
2026-01-161350CALL0 056.27TRUE00
2026-01-16140169.42CALL0 155.46TRUE00
2026-01-161450CALL0 056.17TRUE00
2026-01-161500CALL0 055.53TRUE00
2026-01-161550CALL0 055.49TRUE00
2026-01-16160145CALL0 155.47TRUE00
2026-01-161650CALL0 055.38TRUE00
2026-01-16170143CALL0 155.04TRUE00
2026-01-161750CALL0 054.54TRUE00
2026-01-161800CALL0 054.6TRUE00
2026-01-16185150CALL0 353.93TRUE00
2026-01-16190103.28CALL0 254.47TRUE00
2026-01-16195134CALL0 153.51TRUE00
2026-01-1620093.7CALL0 1253.27TRUE00
2026-01-162100CALL0 052.65FALSE00
2026-01-16220104.56CALL0 651.86FALSE00
2026-01-1623073.77CALL0 11651.77FALSE00
2026-01-1624067.8CALL0 1951.46FALSE00
2026-01-1625038.98CALL3 952.04FALSE-1.58-0.04
2026-01-1626043.37CALL0 1050.89FALSE00
2026-01-1627032.48CALL3 750.85FALSE32.480
2026-01-1628036.91CALL0 549.57FALSE00
2026-01-1629034.15CALL0 1249.23FALSE00
2026-01-1630024.35CALL0 4649.79FALSE00
2026-01-1631034.06CALL0 748.46FALSE00
2026-01-1632045.85CALL0 548.21FALSE00
2026-01-1633024.9CALL0 1247.62FALSE00
2026-01-1634066.46CALL0 147.32FALSE00
2026-01-1635019.3CALL0 647.49FALSE00
2026-01-1636055.9CALL0 2446.68FALSE00
2026-01-163700CALL0 046.56FALSE00
2026-01-163800CALL0 046.3FALSE00
2026-01-163900CALL0 045.9FALSE00
2026-01-1640047CALL0 145.97FALSE00
2026-01-164100CALL0 045.78FALSE00
2026-01-1642040.6CALL0 1944.85FALSE00
2026-01-1643010.58CALL0 5245.99FALSE00
2026-01-161057.5PUT0 556.82FALSE00
2026-01-161108.5PUT0 259.26FALSE00
2026-01-161150PUT0 059.17FALSE00
2026-01-161200PUT0 057.85FALSE00
2026-01-161250PUT0 057.34FALSE00
2026-01-161300PUT0 058.07FALSE00
2026-01-161350PUT0 057.05FALSE00
2026-01-161400PUT0 057.62FALSE00
2026-01-161450PUT0 054.46FALSE00
2026-01-1615019.05PUT0 956.22FALSE00
2026-01-1615515PUT0 355.55FALSE00
2026-01-161600PUT0 055.3FALSE00
2026-01-1616522.77PUT0 2054.58FALSE00
2026-01-161700PUT0 054.66FALSE00
2026-01-1617525.04PUT0 3054.35FALSE00
2026-01-1618030PUT0 154.08FALSE00
2026-01-161850PUT0 053.33FALSE00
2026-01-161900PUT0 053.06FALSE00
2026-01-161950PUT0 051.81FALSE00
2026-01-162000PUT0 052.65FALSE00
2026-01-162100PUT0 052.01TRUE00
2026-01-1622040.9PUT0 12151.5TRUE00
2026-01-1623048.5PUT0 47951.32TRUE00
2026-01-1624055PUT0 2051.11TRUE00
2026-01-1625059.16PUT0 21250.55TRUE00
2026-01-1626066.6PUT0 9949.94TRUE00
2026-01-162700PUT0 049.33TRUE00
2026-01-162800PUT0 048.79TRUE00
2026-01-1629078PUT0 10348.75TRUE00
2026-01-163000PUT0 048.73TRUE00
2026-01-163100PUT0 048.57TRUE00
2026-01-163200PUT0 048.36TRUE00
2026-01-163300PUT0 048.03TRUE00
2026-01-163400PUT0 048.09TRUE00
2026-01-16350129.5PUT0 247.32TRUE00
2026-01-163600PUT0 047.52TRUE00
2026-01-163700PUT0 047.28TRUE00
2026-01-163800PUT0 046.99TRUE00
2026-01-163900PUT0 047.04TRUE00
2026-01-164000PUT0 046.82TRUE00
2026-01-164100PUT0 046.13TRUE00
2026-01-164200PUT0 047.43TRUE00
2026-01-164300PUT0 048.7TRUE00

Latest MDGL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$68.85
Jun 13, 2022 7:59 PM EST100$68.89
Jun 13, 2022 7:59 PM EST100$68.835
Jun 13, 2022 7:59 PM EST100$68.835
Jun 13, 2022 7:59 PM EST100$68.98

Madrigal Pharmaceuticals, Inc (MDGL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520171925/0001193125-20-171925-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000031506618001383/0000315066-18-001383-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000031506619001181/0000315066-19-001181-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319007017/0000899243-19-007017-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319007018/0000899243-19-007018-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319007019/0000899243-19-007019-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319012666/0000899243-19-012666-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018628/0000899243-19-018628-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018644/0000899243-19-018644-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018656/0000899243-19-018656-index.htm
2019-07-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018661/0000899243-19-018661-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018669/0000899243-19-018669-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018673/0000899243-19-018673-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319018677/0000899243-19-018677-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319019463/0000899243-19-019463-index.htm
2019-12-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319029126/0000899243-19-029126-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319029135/0000899243-19-029135-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924319029139/0000899243-19-029139-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320005924/0000899243-20-005924-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320005946/0000899243-20-005946-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320007218/0000899243-20-007218-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320007219/0000899243-20-007219-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320007222/0000899243-20-007222-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320007223/0000899243-20-007223-index.htm
2020-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320010009/0000899243-20-010009-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320014567/0000899243-20-014567-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320014568/0000899243-20-014568-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016983/0000899243-20-016983-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016985/0000899243-20-016985-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016987/0000899243-20-016987-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016988/0000899243-20-016988-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016990/0000899243-20-016990-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320016992/0000899243-20-016992-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320021949/0000899243-20-021949-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320022971/0000899243-20-022971-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/0000899243-20-022972-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320024410/0000899243-20-024410-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000089924320024411/0000899243-20-024411-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000090221920000208/0000902219-20-000208-index.htm
2017-12-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1157601/000104746917007712/0001047469-17-007712-index.htm
2017-12-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1157601/000104746917007756/0001047469-17-007756-index.htm
2018-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1157601/000104746918001557/0001047469-18-001557-index.htm
2018-06-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1157601/000104746918004269/0001047469-18-004269-index.htm
2018-06-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1157601/000104746918004274/0001047469-18-004274-index.htm
2018-06-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1157601/000104746918004327/0001047469-18-004327-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1157601/000104746919000725/0001047469-19-000725-index.htm
2017-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465917050803/0001104659-17-050803-index.htm
2017-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465917050880/0001104659-17-050880-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465917067118/0001104659-17-067118-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465917067200/0001104659-17-067200-index.htm
2017-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465917074616/0001104659-17-074616-index.htm
2018-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918016983/0001104659-18-016983-index.htm
2018-04-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1157601/000110465918027846/0001104659-18-027846-index.htm
2018-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465918031046/0001104659-18-031046-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918031122/0001104659-18-031122-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918036933/0001104659-18-036933-index.htm
2018-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918039204/0001104659-18-039204-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918041808/0001104659-18-041808-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465918049982/0001104659-18-049982-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918050014/0001104659-18-050014-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465918066115/0001104659-18-066115-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465918066198/0001104659-18-066198-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465919010941/0001104659-19-010941-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000110465919027633/0001104659-19-027633-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000110465919027684/0001104659-19-027684-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000110465920016479/0001104659-20-016479-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000110465920020752/0001104659-20-020752-index.htm
2018-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1157601/000114036118020146/0001140361-18-020146-index.htm
2018-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1157601/000114036118020147/0001140361-18-020147-index.htm
2019-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000114420419005583/0001144204-19-005583-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000114420419007227/0001144204-19-007227-index.htm
2017-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911017011766/0001179110-17-011766-index.htm
2017-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911017011806/0001179110-17-011806-index.htm
2018-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018003405/0001179110-18-003405-index.htm
2018-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018003406/0001179110-18-003406-index.htm
2018-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018003407/0001179110-18-003407-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008424/0001179110-18-008424-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008426/0001179110-18-008426-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008428/0001179110-18-008428-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008430/0001179110-18-008430-index.htm
2018-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008437/0001179110-18-008437-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008925/0001179110-18-008925-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008926/0001179110-18-008926-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008927/0001179110-18-008927-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008928/0001179110-18-008928-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018008929/0001179110-18-008929-index.htm
2018-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018011555/0001179110-18-011555-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018012858/0001179110-18-012858-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018013009/0001179110-18-013009-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018013019/0001179110-18-013019-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1157601/000117911018013140/0001179110-18-013140-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1157601/000119312519129437/0001193125-19-129437-index.htm
2019-05-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1157601/000119312519147788/0001193125-19-147788-index.htm
2019-05-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1157601/000119312519147796/0001193125-19-147796-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519188020/0001193125-19-188020-index.htm
2019-07-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519192264/0001193125-19-192264-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000119312519214382/0001193125-19-214382-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519214740/0001193125-19-214740-index.htm
2019-10-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312519269284/0001193125-19-269284-index.htm
2019-10-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312519269285/0001193125-19-269285-index.htm
2019-10-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312519269286/0001193125-19-269286-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000119312519285070/0001193125-19-285070-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519285383/0001193125-19-285383-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519310264/0001193125-19-310264-index.htm
2019-12-12424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1157601/000119312519312878/0001193125-19-312878-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312519312884/0001193125-19-312884-index.htm
2019-12-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312519314030/0001193125-19-314030-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1157601/000119312520049021/0001193125-20-049021-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520049289/0001193125-20-049289-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1157601/000119312520126529/0001193125-20-126529-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000119312520135312/0001193125-20-135312-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520135706/0001193125-20-135706-index.htm
2020-06-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312520157417/0001193125-20-157417-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520171925/0001193125-20-171925-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000119312520211214/0001193125-20-211214-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520211413/0001193125-20-211413-index.htm
2020-09-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1157601/000119312520240245/0001193125-20-240245-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1157601/000119312520286117/0001193125-20-286117-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520286334/0001193125-20-286334-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1157601/000119312520286378/0001193125-20-286378-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1157601/000119312520286414/0001193125-20-286414-index.htm
2020-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1157601/000119312520286429/0001193125-20-286429-index.htm
2018-08-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000142284818000399/0001422848-18-000399-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000142284819000077/0001422848-19-000077-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1157601/000142284820000063/0001422848-20-000063-index.htm
2019-03-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1157601/999999999719000994/9999999997-19-000994-index.htm

Madrigal Pharmaceuticals, Inc (MDGL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Madrigal Pharmaceuticals, Inc (MDGL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1947%
Institutional Ownership: 9386%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-21DAVID V MILLIGANDirectorSell20,000.00112.542,250,800.000.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320005924/0000899243-20-005924-index.htm
2017-08-21Richard S LevyDirectorBuy100.0015.701,570.001,000.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy100.0015.721,572.001,100.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2018-06-11BAY CITY CAPITAL LLCDirectorSell5,908.00287.461,698,313.68113,472.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008424/0001179110-18-008424-index.htm
2018-06-11FRED B CRAVESDirectorSell5,908.00287.461,698,313.68113,472.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008430/0001179110-18-008430-index.htm
2017-08-21Richard S LevyDirectorBuy200.0015.773,154.001,300.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy200.0015.793,158.001,500.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2018-11-19PAUL A FRIEDMANChief Executive OfficerBuy4,000.00124.00496,000.00157,128.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018013019/0001179110-18-013019-index.htm
2018-11-20PAUL A FRIEDMANChief Executive OfficerBuy4,000.00117.88471,520.00161,128.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018013140/0001179110-18-013140-index.htm
2017-08-21Richard S LevyDirectorBuy400.0015.806,320.001,900.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy10.0015.90159.001,910.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2018-09-18DAVID V MILLIGANDirectorBuy20,000.009.45189,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018011555/0001179110-18-011555-index.htm
2018-11-19DAVID V MILLIGANDirectorSell10,000.00131.601,316,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320005946/0000899243-20-005946-index.htm
2017-08-21Richard S LevyDirectorBuy200.0015.933,186.002,110.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy200.0016.023,204.002,310.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy210.0016.043,368.402,520.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-21Richard S LevyDirectorBuy440.0016.077,070.802,960.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2018-11-19FRED B CRAVESDirectorBuy100.00123.1712,317.00296,167.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018013009/0001179110-18-013009-index.htm
2018-11-19FRED B CRAVESDirectorBuy1,000.00124.57124,570.00297,167.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018013009/0001179110-18-013009-index.htm
2018-11-19FRED B CRAVESDirectorBuy900.00125.00112,500.00298,067.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018013009/0001179110-18-013009-index.htm
2018-11-14DAVID V MILLIGANDirectorBuy10,000.0016.46164,600.0030,000.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018012858/0001179110-18-012858-index.htm
2017-08-21Richard S LevyDirectorBuy590.0016.099,493.103,550.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-22Richard S LevyDirectorBuy90.0015.991,439.103,640.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011766/0001179110-17-011766-index.htm
2017-08-22Richard S LevyDirectorBuy389.0016.106,262.904,029.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011766/0001179110-17-011766-index.htm
2019-12-13BAY CITY CAPITAL LLC10% Share HolderSell1,174,680.00105.47123,893,499.604,089,702.00https://www.sec.gov/Archives/edgar/data/1157601/000089924319029139/0000899243-19-029139-index.htm
2019-12-13FRED B CRAVESDirectorSell1,174,680.00105.47123,893,499.604,089,702.00https://www.sec.gov/Archives/edgar/data/1157601/000089924319029135/0000899243-19-029135-index.htm
2018-06-11Marc R SchneebaumChief Financial OfficerSell10,099.00287.462,903,058.5441,668.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008437/0001179110-18-008437-index.htm
2020-08-19BAY CITY CAPITAL LLC10% Share HolderSell7,303.00107.64786,094.9242,875.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/0000899243-20-022972-index.htm
2020-08-19FRED B CRAVESDirectorSell7,303.00107.64786,094.9242,875.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022971/0000899243-20-022971-index.htm
2018-06-11Marc R SchneebaumChief Financial OfficerBuy5,223.0099.75520,994.2549,033.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008437/0001179110-18-008437-index.htm
2020-08-18BAY CITY CAPITAL LLC10% Share HolderSell10,197.00110.031,121,975.9150,178.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/0000899243-20-022972-index.htm
2020-08-18FRED B CRAVESDirectorSell10,197.00110.031,121,975.9150,178.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022971/0000899243-20-022971-index.htm
2018-06-11Marc R SchneebaumChief Financial OfficerBuy2,734.0061.60168,414.4051,767.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008437/0001179110-18-008437-index.htm
2018-06-11BAY CITY CAPITAL LLCDirectorSell274,092.00287.4678,790,486.325,264,382.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008424/0001179110-18-008424-index.htm
2018-06-11FRED B CRAVESDirectorSell274,092.00287.4678,790,486.325,264,382.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008430/0001179110-18-008430-index.htm
2020-08-17BAY CITY CAPITAL LLC10% Share HolderSell12,500.00110.731,384,125.0060,375.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/0000899243-20-022972-index.htm
2020-08-17FRED B CRAVESDirectorSell12,500.00110.731,384,125.0060,375.00https://www.sec.gov/Archives/edgar/data/1157601/000089924320022971/0000899243-20-022971-index.htm
2018-06-11PAUL A FRIEDMANChief Executive OfficerSell73,526.00287.4621,135,783.96655,540.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008428/0001179110-18-008428-index.htm
2018-06-11Rebecca TaubChief Medical Officer, EVP R&DSell73,526.00287.4621,135,783.96655,540.00https://www.sec.gov/Archives/edgar/data/1157601/000117911018008426/0001179110-18-008426-index.htm
2017-08-22Richard S LevyDirectorBuy2,944.0016.1247,457.286,973.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011766/0001179110-17-011766-index.htm
2017-08-22Richard S LevyDirectorBuy127.0016.142,049.787,100.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011766/0001179110-17-011766-index.htm
2017-08-23Richard S LevyDirectorBuy100.0016.081,608.007,200.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011806/0001179110-17-011806-index.htm
2017-08-23Richard S LevyDirectorBuy100.0016.111,611.007,300.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011806/0001179110-17-011806-index.htm
2019-12-13BAY CITY CAPITAL LLC10% Share HolderSell25,320.00105.472,670,500.4088,152.00https://www.sec.gov/Archives/edgar/data/1157601/000089924319029139/0000899243-19-029139-index.htm
2019-12-13FRED B CRAVESDirectorSell25,320.00105.472,670,500.4088,152.00https://www.sec.gov/Archives/edgar/data/1157601/000089924319029135/0000899243-19-029135-index.htm
2017-08-21Richard S LevyDirectorBuy900.0015.6714,103.00900.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011725/0001179110-17-011725-index.htm
2017-08-23Richard S LevyDirectorBuy1,793.0016.1228,903.169,093.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011806/0001179110-17-011806-index.htm
2017-08-23Richard S LevyDirectorBuy7.0016.25113.759,100.00https://www.sec.gov/Archives/edgar/data/1157601/000117911017011806/0001179110-17-011806-index.htm